Please ensure Javascript is enabled for purposes of website accessibility

3 Huge Growth Opportunities for This Health Care Giant

By Dan Carroll – Sep 27, 2013 at 10:45AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stryker's changing its image in 2013 as it makes moves in innovative technologies, emerging markets, and more.

Orthopedics device maker Stryker (SYK 0.97%) might be one of the biggest names in medical tech, but this stock's not often thought of as a great growth opportunity. However, Stryker's changing the game in 2013: The company has paved a path for future growth that just grew clearer this week, when the company purchased robotic surgery maker MAKO Surgical (MAKO.DL).

MAKO Surgical hasn't performed as well as investors thought. Robotics forerunner Intuitive Surgical (ISRG -0.82%) lit the path for MAKO by pushing its da Vinci surgical suite to hospitals across the U.S., and Intuitive's stock has succeeded over the past few years because of its strong sales, consistent earnings growth, and expanded approvals for new surgical indications. That hasn't caught up to MAKO yet: The company hasn't even reached profitability. But as part of Stryker's portfolio, this once-controversial stock could become a significant portion of a top device maker's future.

Stryker's strategy doesn't end with MAKO, however. In the video below, Fool contributor Dan Carroll tells you what's ahead for Stryker in the wake of the MAKO acquisition -- and what other top moves the company's making to solidify its stock's growth in the long run.

Fool contributor Dan Carroll has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

MAKO Surgical Corp. Stock Quote
MAKO Surgical Corp.
Stryker Stock Quote
$243.11 (0.97%) $2.34
Intuitive Surgical Stock Quote
Intuitive Surgical
$272.25 (-0.82%) $-2.24

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.